Skip to main content
Nutex Health, Inc. logo

Nutex Health, Inc. — Investor Relations & Filings

Ticker · NUTX ISIN · US18727D1054 LEI · 254900RSD2OET3HENJ50 US Human health and social work activities
Open in API
Filings indexed 489 across all filing types
Latest filing 2023-09-05 Board/Management Inform…
Country US United States of America
Listing US NUTX

About Nutex Health, Inc.

https://www.nutexhealth.com/

Nutex Health, Inc. is a physician-led healthcare management and operations company structured into two core divisions: a Hospital Division and a Population Health Management Division. The Hospital Division develops, owns, and operates a network of facilities, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). These facilities provide 24/7 emergency services, inpatient care, and specialized treatments such as behavioral health and detoxification. The Population Health Management Division owns and operates provider networks, such as Independent Physician Associations (IPAs), and provides comprehensive administrative and management support to physician groups through its Management Services Organizations (MSOs), aiming to improve care delivery and operational efficiency.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated August 28, 2023, by Nutex Health Inc. The key content is the appointment of a new Chief Operating Officer, Joshua DeTillio, including details about his background, employment agreement, compensation, and terms. The document also includes a press release as an exhibit. The primary focus is on a change in senior management, specifically the appointment of an executive officer. There are no financial statements or earnings data presented, nor is this a report of voting results or a regulatory compliance filing unrelated to management changes. Therefore, the document fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2023-09-05 English
PRIMARY DOCUMENT
Director's Dealing
2023-09-01 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions an acquisition event and includes a press release as an exhibit. The document length is 3645 characters, which is relatively short and primarily serves as an announcement rather than a detailed report. There are no financial statements or detailed financial data included. The document is not an annual or quarterly report, audit report, or earnings release. It is not a proxy statement, governance report, or management discussion. The key content is the announcement of an acquisition event and the attached press release. According to the filing definitions, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes Form 8-K filings announcing events.
2023-08-23 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 9, 2023, reporting the company's financial and operating results for the quarter ending June 30, 2023. It references a press release attached as Exhibit 99.1. The document is relatively short (3619 characters) and primarily serves as a current report to announce quarterly results, not a full detailed financial report. Form 8-K filings with Item 2.02 (Results of Operations and Financial Condition) typically correspond to Earnings Releases or initial announcements of quarterly financial results. Therefore, the document fits best under the Earnings Release (ER) category.
2023-08-09 English
10-Q
Interim / Quarterly Report Q2 2023
2023-08-09 English
S-8
Capital/Financing Update Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Nutex Health Inc. It registers shares of common stock to be issued under employee benefit plans, specifically the 2023 Equity Incentive Plan and the 2023 Employee Stock Purchase Plan. The document includes legal and procedural information about the registration, indemnification provisions, and references to other filings such as the Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Form S-8 is a registration statement used for securities to be offered to employees under stock plans and is not a financial report, earnings release, or management discussion. It is a capital/financing related filing as it pertains to the registration of securities for issuance under equity incentive plans. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the registration statement itself, not just an announcement or a certification, so it is not RPA or RNS.
2023-07-25 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.